Andrew Oxtoby's most recent trade in Kalaris Therapeutics Inc. was a trade of 287,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 10, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Kalaris Therapeutics Inc. | Andrew Oxtoby | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 287,000 | 287,000 | - | - | Stock Option (Right to Buy) |